Grand Pharmaceutical Group Limited (SEHK: 512)
Health Care · Pharmaceuticals · HK
HK$4.74
-1.76% today · -43.5% 1Y
Grand Pharmaceutical Group Limited (SEHK: 512) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.12B.
Over the last twelve months the share price has lost 43.5%, trading between 4.53 and 8.97.
Tweenvest scores Grand Pharmaceutical Group Limited across four factors: quality 76/100, value 53/100, growth 25/100, dividend 34/100. Its strongest factor is quality.
512 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.12B
- Revenue (TTM)
- $1.59B
- P/E
- 14.96
- EPS
- 0.32
- Dividend yield
- 3.57%
- Beta (5Y)
- 0.68
- 52-week high
- HK$8.97
- 52-week low
- HK$4.53
- Avg volume (3M)
- —
- Shares outstanding
- 3.50B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BrightGene Bio-Medical Technology Co., Ltd.SHSE: 688166 | $2.18B | CN¥33.53 | -6.37% |
| Tonghua Golden-Horse Pharmaceutical Industry Co,LtdSZSE: 000766 | $2.16B | CN¥14.97 | -1.25% |
| China Resources Jiangzhong Pharmaceutical Co.,LtdSHSE: 600750 | $2.15B | CN¥22.88 | +1.24% |
| Dermapharm Holding SEXTRA: DMP | $2.13B | €38.30 | -0.26% |
| Zhejiang Jiuzhou Pharmaceutical Co., LtdSHSE: 603456 | $2.09B | CN¥16.31 | -2.63% |
| Perrigo Company plcNYSE: PRGO | $2.09B | $15.41 | +2.32% |
| Granules India LimitedBSE: 532482 | $2.08B | Rs813.85 | -0.85% |
| Zhejiang Hisun Pharmaceutical Co., Ltd.SHSE: 600267 | $2.06B | CN¥11.94 | +1.62% |
Figures last refreshed Oct 11, 2026.